Key result
Chronic oral administration of nitro-L-arginine for 4-6 weeks in rats induced severe arterial hypertension, with tail-cuff pressure reaching 164 +/- 6 mm Hg compared to 108 +/- 3 mm Hg in controls.
Why the study?
Does chronic nitric oxide blockade with nitro-L-arginine induce arterial hypertension and renal vasoconstriction in Munich-Wistar rats?
Does chronic nitric oxide blockade with nitro-L-arginine induce arterial hypertension and renal vasoconstriction in Munich-Wistar rats?
Chronic nitric oxide blockade with nitro-L-arginine in rats creates a new model of severe arterial hypertension characterized by marked renal vasoconstriction and hypoperfusion.
Answers are grounded in this paper and cite their sources.
Caution against human extrapolation; extends experimental models of nitric oxide deficiency in hypertension.
Recent studies have indicated that acute inhibition of nitric oxide biosynthesis in the rat promotes arterial hypertension and renal vasoconstriction. We evaluated the renal and systemic effects of 4-6 weeks of nitric oxide blockade in Munich-Wistar rats receiving the nitric oxide inhibitor nitro-L-arginine orally. Age-matched untreated rats were used as controls. In an additional seven rats, nitric oxide blockade was carried out in conjunction with oral administration of the novel angiotensin II antagonist losartan potassium. Tail-cuff pressure rose progressively in nitro-L-arginine-treated rats, reaching 164 +/- 6 mm Hg at 4-6 weeks, compared with 108 +/- 3 mm Hg in controls. In rats concomitantly receiving losartan, tail-cuff pressure reached 125 +/- 6 mm Hg, still elevated compared with rats receiving losartan alone (98 +/- 3 mm Hg). Nitro-L-arginine-treated rats presented marked renal vasoconstriction and hypoperfusion, as well as a 30% fall in glomerular filtration rate and a 39% increase in filtration fraction. Treatment with Losartan normalized glomerular filtration rate, but not filtration fraction or renal vascular resistance. Plasma renin activity was elevated after nitro-L-arginine treatment. Renal histological examination revealed widespread arteriolar narrowing, focal arteriolar obliteration, and segmental fibrinoid necrosis in the glomeruli. In a separate group of rats, nitro-L-arginine administered for 1 week induced hypertension that was partially reversed by acute L-arginine, but not D-arginine or L-glycine, infusions. We conclude that chronic nitric oxide blockade may constitute a new model of severe arterial hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Ribeiro et al. (1992) studied Arterial hypertension. nitro-L-arginine vs. untreated controls was evaluated on Tail-cuff pressure. Chronic oral administration of nitro-L-arginine for 4-6 weeks in rats induced severe arterial hypertension, with tail-cuff pressure reaching 164 +/- 6 mm Hg compared to 108 +/- 3 mm Hg in controls.
Synapse has enriched 10 related papers. Consider them for comparative context: